Specific correlation between the wobble modification deficiency in mutant tRNAs and the clinical features of a human
Yohei Kirino1, Yu-Ichi Goto, Yolanda Campos
1Department of Chemistry and Biotechnology, Graduate School of Engineering, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8656, Japan.
Abstract:
Mutations in mtDNA are responsible for a variety of mitochondrial diseases, where the mitochondrial tRNA(Leu(UUR)) gene has especially hot spots for pathogenic mutations. Clinical features often depend on the tRNA species and/or positions of the mutations; however, molecular pathogenesis elucidating the relation between the location of the mutations and their leading phenotype are not fully understood. We report here that mitochondrial tRNAs(Leu(UUR)) harboring one of five mutations found in tissues from patients with symptoms of mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) (A3243G, G3244A, T3258C, T3271C, and T3291C) lacked the normal taurine-containing modification (5-taurinomethyluridine) at the anticodon wobble position. In contrast, mitochondrial tRNAs(Leu(UUR)) with different mutations found in patients that have mitochondrial diseases but do not show the MELAS symptoms (G3242A, T3250C, C3254T, and A3280G) had the normal 5-taurinomethyluridine modifications. These observations were made by using a modified primer extension technique that can detect the modification deficiency in the extremely limited quantities of mutant tRNAs obtainable from patient tissues. These results strongly suggest deficient wobble modification could be a key molecular factor responsible for the phenotypic features of MELAS, which can explain why the different MELAS-associated mutations result in indistinguishable clinical features.
Insights
Mitochondrial tRNA(Leu(UUR)) mutations linked to MELAS symptoms lack normal wobble modifications. This deficiency in 5-taurinomethyluridine may explain the specific clinical features of mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes.
Area of Science:
- Genetics
- Molecular Biology
- Biochemistry
Background:
- Mitochondrial DNA (mtDNA) mutations cause various mitochondrial diseases.
- The mitochondrial tRNA(Leu(UUR)) gene is a common site for pathogenic mutations.
- The precise molecular mechanisms linking mutation location to specific disease phenotypes remain unclear.
Purpose of the Study:
- To investigate the role of tRNA modifications in the pathogenesis of mitochondrial diseases.
- To determine if specific tRNA mutations correlate with the absence of normal modifications.
- To elucidate the molecular basis for the distinct clinical features observed in MELAS patients.
Main Methods:
- A modified primer extension technique was employed.
- This method detected modification deficiencies in limited patient tissue samples.
- Analysis focused on mitochondrial tRNAs(Leu(UUR)) with known pathogenic mutations.
Main Results:
- Mutations associated with MELAS (A3243G, G3244A, T3258C, T3271C, T3291C) resulted in a lack of 5-taurinomethyluridine modification at the anticodon wobble position.
- Mutations in patients without MELAS symptoms retained normal 5-taurinomethyluridine modifications.
- Deficient wobble modification was observed in MELAS-associated tRNA(Leu(UUR)) mutations.
Conclusions:
- Deficient wobble modification of mitochondrial tRNA(Leu(UUR)) is strongly suggested as a key factor in MELAS pathogenesis.
- This modification deficiency may explain the consistent clinical presentation of MELAS despite diverse underlying mutations.
- The findings provide a molecular link between mutation location and the MELAS phenotype.
Related Concept Videos
Pleiotropy
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Animal Mitochondrial Genetics
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
ATP Synthase: Mechanism
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life


